PE66798A1 - Analogos de la vitamina d3 tratados con fluor - Google Patents
Analogos de la vitamina d3 tratados con fluorInfo
- Publication number
- PE66798A1 PE66798A1 PE1997000387A PE00038797A PE66798A1 PE 66798 A1 PE66798 A1 PE 66798A1 PE 1997000387 A PE1997000387 A PE 1997000387A PE 00038797 A PE00038797 A PE 00038797A PE 66798 A1 PE66798 A1 PE 66798A1
- Authority
- PE
- Peru
- Prior art keywords
- link
- compounds
- carbon
- double
- analogs
- Prior art date
Links
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 title 1
- 229910052731 fluorine Inorganic materials 0.000 title 1
- 239000011737 fluorine Substances 0.000 title 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 abstract 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical group C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "X" ES =CH2 O SON HIDROGENO; R1 Y R2 SON DE PREFERENCIA H, CF3 O CH3, o R1 Y R2 JUNTO CON EL CARBONO 20 FORMAN UN CICLOFLUOROALQUILO O CICLOALQUILO C3-C6, o R1 Y R2 JUNTOS FORMAN =CH2; R3 Y R4 SON DE PREFERENCIA CH3, CF3, CH2CH3, CH2CF3, CF2CH3 Y CF2CF3 o R3 Y R4 JUNTO CON EL CARBONO 25 FORMAN UN CICLOFLUOROALQUILO O CICLOALQUILO C3-C9; "A" ES UN ENLACE SIMPLE O DOBLE; "B" ES UN ENLACE DOBLE O TRIPLE; SIEMPRE QUE: CUANDO "X" ES =CH2, "A" ES UN ENLACE DOBLE, Y: (i) R3 Y R4 SON CF3: SI UNO DE R1 Y R2 ES H, ENTONCES, EL OTRO NO ES CH3; (ii) R3 Y R4 SON ALQUILO C1-C2: SI R2 ES H, ENTONCES, R1 NO ES CH3; (iii) R3 Y R4 SON ALQUILO C1-C4: SI R1 ES H, ENTONCES, R2 NO ES CH3; (iv) R1 ES CH3, R2 ES H: SI UNO DE R3 Y R4 ES CF3, ENTONCES, EL OTRO NO ES CH3; (v) CUANDO "X" SEAN H, R3 Y R4 SON CF3, "A" ES UN ENLACE DOBLE, "B" ES UN ENLACE TRIPLE: SI R2 ES H, ENTONCES, R1 NO ES CH3. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS (I), QUE COMPRENDE ELIMINAR LOS GRUPOS PROTECTORES SILILO; Y A LOS COMPUESTOS INTERMEDIOS DE FORMULA (II), EN DONDE: R1 Y R2 SON CH3 o JUNTO CON EL CARBONO 20 FORMAN UN ANILLO CICLOPROPANO o FORMAN UN =CH2; R3, R4, "A" Y "B" SON COMO SE DEFINIERON PARA (I); "Y" ES H o OSi(CH3)3. LOS COMPUESTOS OBTENIDOS SON USADOS PARA TRATAR LA OSTEOPOROSIS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1821996P | 1996-05-23 | 1996-05-23 | |
US3990197P | 1997-03-19 | 1997-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE66798A1 true PE66798A1 (es) | 1998-10-22 |
Family
ID=26690870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1997000387A PE66798A1 (es) | 1996-05-23 | 1997-05-16 | Analogos de la vitamina d3 tratados con fluor |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0808832B1 (es) |
JP (1) | JP2859248B2 (es) |
KR (1) | KR100253961B1 (es) |
CN (1) | CN100402497C (es) |
AR (1) | AR007776A1 (es) |
AT (1) | ATE238278T1 (es) |
AU (1) | AU733970B2 (es) |
BR (1) | BR9703385A (es) |
CA (1) | CA2205315C (es) |
CO (1) | CO4940503A1 (es) |
CZ (1) | CZ157797A3 (es) |
DE (1) | DE69721123T2 (es) |
DK (1) | DK0808832T3 (es) |
ES (1) | ES2195049T3 (es) |
HR (1) | HRP970272A2 (es) |
HU (1) | HUP9700928A3 (es) |
IL (1) | IL120844A0 (es) |
MA (1) | MA24250A1 (es) |
NO (1) | NO972278L (es) |
NZ (1) | NZ314840A (es) |
PE (1) | PE66798A1 (es) |
PL (1) | PL320130A1 (es) |
PT (1) | PT808832E (es) |
SG (1) | SG70010A1 (es) |
TR (1) | TR199700416A2 (es) |
YU (1) | YU20097A (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
DE19935771A1 (de) | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
WO2002013832A1 (fr) * | 2000-08-17 | 2002-02-21 | Chugai Seiyaku Kabushiki Kaisha | Agent therapeutique destine au traitement de l'osteoporose |
CA2459789A1 (en) * | 2001-09-21 | 2003-04-03 | F. Hoffmann-La Roche Ag | 3-desoxy-vitamin d3 analog esters |
US7332482B2 (en) | 2003-09-24 | 2008-02-19 | Bioxell S.P.A. | Method for treating benign prostatic hyperplasia |
JP2008514621A (ja) * | 2004-09-24 | 2008-05-08 | ビオクセル エッセ ピ ア | 20−シクロアルキル,26,27−アルキル/ハロアルキル−ビタミンd3化合物及びその使用方法 |
US20090099140A1 (en) * | 2005-03-23 | 2009-04-16 | Bioxell S.P.A. | 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof |
BR112013009647A2 (pt) | 2010-10-25 | 2016-07-12 | Teijin Pharma Ltd | derivado de vitamina, composição farmacêutica, agente terapêutico, e, composto |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4141746A1 (de) * | 1991-12-13 | 1993-06-17 | Schering Ag | 20-methyl-substituierte vitamin d-derivate |
DE4220757A1 (de) * | 1992-06-24 | 1994-01-05 | Schering Ag | Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
US5384314B1 (en) * | 1994-03-11 | 1997-08-05 | Hoffmann La Roche | 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol |
WO1997016193A1 (en) * | 1995-10-27 | 1997-05-09 | F. Hoffmann-La Roche Ag | Pharmaceutical composition for treating osteoporosis |
-
1997
- 1997-05-12 SG SG1997001484A patent/SG70010A1/en unknown
- 1997-05-14 EP EP97107868A patent/EP0808832B1/en not_active Expired - Lifetime
- 1997-05-14 CA CA002205315A patent/CA2205315C/en not_active Expired - Fee Related
- 1997-05-14 DK DK97107868T patent/DK0808832T3/da active
- 1997-05-14 DE DE69721123T patent/DE69721123T2/de not_active Expired - Lifetime
- 1997-05-14 AT AT97107868T patent/ATE238278T1/de not_active IP Right Cessation
- 1997-05-14 ES ES97107868T patent/ES2195049T3/es not_active Expired - Lifetime
- 1997-05-14 PT PT97107868T patent/PT808832E/pt unknown
- 1997-05-16 IL IL12084497A patent/IL120844A0/xx unknown
- 1997-05-16 PE PE1997000387A patent/PE66798A1/es not_active Application Discontinuation
- 1997-05-16 NZ NZ314840A patent/NZ314840A/en unknown
- 1997-05-20 NO NO972278A patent/NO972278L/no unknown
- 1997-05-20 YU YU20097A patent/YU20097A/sh unknown
- 1997-05-20 HR HR60/039,901A patent/HRP970272A2/xx not_active Application Discontinuation
- 1997-05-21 HU HU9700928A patent/HUP9700928A3/hu unknown
- 1997-05-21 MA MA24631A patent/MA24250A1/fr unknown
- 1997-05-21 AR ARP970102159A patent/AR007776A1/es active IP Right Grant
- 1997-05-22 KR KR1019970020029A patent/KR100253961B1/ko not_active IP Right Cessation
- 1997-05-22 JP JP9131810A patent/JP2859248B2/ja not_active Expired - Fee Related
- 1997-05-22 AU AU23576/97A patent/AU733970B2/en not_active Ceased
- 1997-05-22 CN CNB971134324A patent/CN100402497C/zh not_active Expired - Fee Related
- 1997-05-22 CZ CZ971577A patent/CZ157797A3/cs unknown
- 1997-05-22 PL PL97320130A patent/PL320130A1/xx unknown
- 1997-05-22 CO CO97028096A patent/CO4940503A1/es unknown
- 1997-05-23 BR BR9703385A patent/BR9703385A/pt not_active Application Discontinuation
- 1997-05-23 TR TR97/00416A patent/TR199700416A2/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4950531A1 (es) | Analogos de la vitamina d3 composciiones farmaceuticas que los contienen | |
ES2055056T3 (es) | Derivados de pirimidopirimidina. | |
ES2011210T3 (es) | Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX9300031A (es) | Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene. | |
ES2045180T3 (es) | Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas. | |
ES526318A0 (es) | Procedimiento para la obtencion de derivados de 1-hidroxietil-triazolilo sustituidos | |
AR247402A1 (es) | Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos | |
PE66798A1 (es) | Analogos de la vitamina d3 tratados con fluor | |
AR036000A1 (es) | Proceso para la preparacion de derivados de indol y novedosos intermediarios | |
ES449096A1 (es) | Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas. | |
ES2145563T3 (es) | Nuevos derivados de la imidazolina con una afinidad para los receptores imidazolinicos. | |
DK121383D0 (da) | Fremgangsmade til fremstilling af 8-substituerede pyrrolizidinderivater | |
SE8003278L (sv) | Fenyletylaminderivat | |
PT83452A (en) | Process for preparing alkylmercaptaophenyl-1,3,4-oxa (or thia) iazole derivatives and nematicidal compositions therewith | |
SE9002596D0 (sv) | A method for synthesis of prostaglandin derivatives | |
PA8475701A1 (es) | Derivados de 3(2-oxo-[1,3']bipirrolidinil-3-ilidenmetil)-cephems | |
EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные | |
AU583247B2 (en) | Heteroaryloxypropanolamines | |
ES2032461T3 (es) | Procedimiento para preparar derivados de indol. | |
ES2145905T3 (es) | Procedimiento de produccion de acido 3-isoxazolcarboxilico. | |
ES520136A0 (es) | Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico | |
PE69199A1 (es) | Derivados de arilsecocoladieno | |
ES2043605T3 (es) | Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol. | |
ES2169881T3 (es) | Nuevos derivados de amida de pirrolidina sustituidos con heterociclo. | |
DK56285A (da) | Carbacykliner, fremgangsmaade til fremstilling deraf, samt deres anvendelse som laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |